Impact of the CYP2C8*3 polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone
Impact of the CYP2C8*3 polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone
复制标题
DOI：
10.1111/j.1365-2125.2012.04343.x
复制
发表时间：
2013-01-01
影响因子：
3.4
通讯作者：
Sidhom, Maha S.
中科院分区：
文献类型：
--
作者：
Aquilante, Christina L.;Kosmiski, Lisa A.;Sidhom, Maha S.
AIMThe objective of this study was to determine the extent to which the CYP2C8*3 allele influences pharmacokinetic variability in the drugdrug interaction between gemfibrozil (CYP2C8 inhibitor) and pioglitazone (CYP2C8 substrate).METHODSIn this randomized, two phase crossover study, 30 healthy Caucasian subjects were enrolled based on CYP2C8*3 genotype (n= 15, CYP2C8*1/*1; n= 15, CYP2C8*3 carriers). Subjects received a single 15 mg dose of pioglitazone or gemfibrozil 600 mg every 12 h for 4 days with a single 15 mg dose of pioglitazone administered on the morning of day 3. A 48 h pharmacokinetic study followed each pioglitazone dose and the study phases were separated by a 14 day washout period.RESULTSGemfibrozil significantly increased mean pioglitazone AUC(0,8) by 4.3-fold (P < 0.001) and there was interindividual variability in the magnitude of this interaction (range, 1.8- to 12.1-fold). When pioglitazone was administered alone, the mean AUC(0,8) was 29.7% lower (P= 0.01) in CYP2C8*3 carriers compared with CYP2C8*1 homozygotes. The relative change in pioglitazone plasma exposure following gemfibrozil administration was significantly influenced by CYP2C8 genotype. Specifically, CYP2C8*3 carriers had a 5.2-fold mean increase in pioglitazone AUC(0,8) compared with a 3.3-fold mean increase in CYP2C8*1 homozygotes (P= 0.02).CONCLUSIONCYP2C8*3 is associated with decreased pioglitazone plasma exposure in vivo and significantly influences the pharmacokinetic magnitude of the gemfibrozilpioglitazone drug-drug interaction. Additional studies are needed to evaluate the impact of CYP2C8 genetics on the pharmacokinetics of other CYP2C8-mediated drugdrug interactions.
